Gomes André, da Silva Inês V, Rodrigues Cecília M P, Castro Rui E, Soveral Graça
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Department Bioquimica e Biologia Humana, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Front Chem. 2018 Jun 21;6:238. doi: 10.3389/fchem.2018.00238. eCollection 2018.
Aquaporins (AQPs) are membrane channels widely distributed in human tissues. AQPs are essential for water and energy homeostasis being involved in a broad range of pathophysiological processes such as edema, brain injury, glaucoma, nephrogenic diabetes insipidus, salivary and lacrimal gland dysfunction, cancer, obesity and related metabolic complications. Compelling evidence indicates that AQPs are targets for therapeutic intervention with potential broad application. Nevertheless, efficient AQP modulators have been difficult to find due to either lack of selectivity and stability, or associated toxicity that hamper studies. MicroRNAs (miRNAs) are naturally occurring small non-coding RNAs that regulate post-transcriptional gene expression and are involved in several diseases. Recent identification of miRNAs as endogenous modulators of AQP expression provides an alternative approach to target these proteins and opens new perspectives for therapeutic applications. This mini-review compiles the current knowledge of miRNA interaction with AQPs highlighting miRNA potential for regulation of AQP-based disorders.
水通道蛋白(AQPs)是广泛分布于人体组织中的膜通道。水通道蛋白对于水和能量稳态至关重要,参与多种病理生理过程,如水肿、脑损伤、青光眼、肾性尿崩症、唾液腺和泪腺功能障碍、癌症、肥胖及相关代谢并发症。有力证据表明,水通道蛋白是具有潜在广泛应用的治疗干预靶点。然而,由于缺乏选择性和稳定性或存在相关毒性阻碍研究,高效的水通道蛋白调节剂一直难以找到。微小RNA(miRNAs)是天然存在的小非编码RNA,可调节转录后基因表达并参与多种疾病。最近将微小RNA鉴定为水通道蛋白表达的内源性调节剂,为靶向这些蛋白质提供了一种替代方法,并为治疗应用开辟了新的前景。本综述汇编了当前关于微小RNA与水通道蛋白相互作用的知识,突出了微小RNA在调节基于水通道蛋白的疾病方面的潜力。